Consensus Abbott Laboratories Wiener Boerse

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 23:00:02 02/09/2026 +03			5-day change	1st Jan Change
95.35 ^EUR	-1.48%		-2.02%	-8.66%

09-01	Mead Johnson wins US federal bellwether trial over preterm infant formula Enfamil	RE
09-01	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

9164d8e2eeb0aa36edf77.9OttWEznp32zylGi5Tht1ZbNXd0fJQtvtVrqcce6i-Q.uJpdbTuG1DT-mDLbsQoy5Mf9FZZMdyYs1h-lXIHV-bGzqVptKpTKTfaMFA~1e8db9ba9be1563af933685d2ab78eaa

Analysts' recommendations: Abbott Laboratories

08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
07-01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
06-12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
05-27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05-05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
04-22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
04-22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
04-21	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
04-21	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
04-20	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+10.35%
	MEDTRONIC PLC					+9.52%
	CENCORA, INC.					+11.58%
	HOYA CORPORATION					+23.21%
	BECTON, DICKINSON AND COMPANY					+4.57%
	DEXCOM, INC.					+4.42%
	MEDLINE INC.					+27.07%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.51%
	TERUMO CORPORATION					+23.13%
	Average					+14.82%
	Weighted average by Cap.					+12.38%